Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Gliosarcoma 87Glioblastoma 85Sarcoma 82Central Nervous System Neoplasms 50Dendritic Cell Sarcoma, Interdigitating 33Lymphoma 31Burkitt Lymphoma 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, Non-Hodgkin 26Lymphoma, Large-Cell, Immunoblastic 26Lymphoma, Large B-Cell, Diffuse 26Leukemia 26Lymphoma, Follicular 24Lymphoma, Mantle-Cell 23Myelodysplastic Syndromes 22Leukemia, Lymphocytic, Chronic, B-Cell 22Lymphoma, B-Cell, Marginal Zone 21Leukemia, Myeloid, Chronic-Phase 21Recurrence 20Astrocytoma 20Leukemia, Myeloid, Accelerated Phase 19Hodgkin Disease 19Blast Crisis 18Multiple Myeloma 17Leukemia, Myeloid, Acute 17Liposarcoma 16Glioma 16Rhabdomyosarcoma 15Neoplasms, Plasma Cell 15Brain Neoplasms 14

Interventions

Nivolumab 6Imatinib Mesylate 4Ipilimumab 3Cetuximab 3pembrolizumab 2palbociclib 2Specimen Handling 2Radiotherapy 2Radiosurgery 2Protons 2Proton Therapy 2Pemetrexed 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2tazemetostat 1spartalizumab 1relatlimab 1nilotinib 1camrelizumab 1avelumab 1atezolizumab 1apatinib 1Zoledronic Acid 1X-Rays 1Tiragolumab 1Thiotepa 1Surveys and Questionnaires 1Radiotherapy, Intensity-Modulated 1Radiation 1Photochemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Chordoma × Radiotherapy × Sarcoma × Clear all
NCT01407198 2025-12-19

Nilotinib With Radiation for High Risk Chordoma

Massachusetts General Hospital

Phase 1 Completed
23 enrolled
Sarcoma

Chordoma

NCT02383498 2024-05-20

QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma

NantCell, Inc.

Phase 2 Completed
24 enrolled 8 charts
Sarcoma

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡